Position of Teamleader and Leadership Performance (LeadPos)

Effect of the Position of the Teamleader on Quality of Leadership and Team Performance

Investigation in simulated cardiac arrests. Team leaders are randomly designated. Designated teamleaders are instructed to lead their team from the position of the patient's head or remote from the patient.

Study Overview

• Status: Completed
• Conditions: Leadership
• Intervention / Treatment: Behavioral: position

Detailed Description

participants: physicians taking part in voluntary simulator-based workshops. Teams of 3-4 are formed. One teammember is randomly allocated as teamleader design: prospective, randomized, single-blind, cross-over intervention: teamleaders are randomized and instructed to lead their team from the conventional position at the patient's head or from a remote hands-off position data analysis: will be performed from videorecordings

• Study Type: Interventional
• Enrollment (Actual): 151
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Switzerland
  • BS
    • Basel, BS, Switzerland, 4031
      • University Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 24 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Physicians taking part in voluntary workshops

Exclusion Criteria:

• refusal to participate and/or being videorecorded

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Other
• Allocation: Randomized
• Interventional Model: Crossover Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Active Comparator: Conventional position (head position); Leaderposition at the patient's head	Behavioral: position; teamleaders are instructed to allocated position
Active Comparator: Remote position; Leaderposition remote from patient and hands-off	Behavioral: position; teamleaders are instructed to allocated position

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Quantity of leadership	Number of leadership utterances made as defined by the adapted Leadership Behaviour Description Questionnaire	5 minutes

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Hands-on time	Hands-on time during the first 5 minutes of the cardiac arrest	5 minutes
Quality of leadership	Type of leadership utterances made as defined by the adapted Leadership Behaviour Description Questionnaire	5 minutes

Collaborators and Investigators

• Sponsor: University Hospital, Basel, Switzerland
• Investigators: Principal Investigator: Stephan Marsch, University Hospital, Basel, Switzerland

Study record dates

Study Major Dates

• Study Start (Actual): March 1, 2017
• Primary Completion (Actual): June 30, 2022
• Study Completion (Actual): September 30, 2022

Study Registration Dates

• First Submitted: March 22, 2021
• First Submitted That Met QC Criteria: March 26, 2021
• First Posted (Actual): April 1, 2021

Study Record Updates

• Last Update Posted (Actual): November 15, 2022
• Last Update Submitted That Met QC Criteria: November 14, 2022
• Last Verified: November 1, 2022

More Information

Terms related to this study

• Keywords: simulation; cardiopulmonary resuscitation; teamleader
• Other Study ID Numbers: 4031-Sim

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: No
• IPD Plan Description: Secondary data can be changed Videorecordings of simulations are strictly confidential and cannot be shared

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No